| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |